Any feedback?
Please rate this page
(enzyme.php)
(0/150)

BRENDA support

Disease on EC 3.4.21.B41 - kallikrein 10

Please use the Disease Search for a specific query.
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
DISEASE
TITLE OF PUBLICATION
LINK TO PUBMED
ACTH-Secreting Pituitary Adenoma
Human Kallikrein 10 Expression in Surgically Removed Human Pituitary Corticotroph Adenomas: An Immunohistochemical Study.
Adenocarcinoma
Co-expression of KLK6 and KLK10 as prognostic factors for survival in pancreatic ductal adenocarcinoma.
Evaluation of human tissue kallikrein-related peptidases 6 and 10 expression in early gastroesophageal adenocarcinoma.
Astrocytoma
Prognostic significance of multiple kallikreins in high-grade astrocytoma.
Barrett Esophagus
Evaluation of human tissue kallikrein-related peptidases 6 and 10 expression in early gastroesophageal adenocarcinoma.
Breast Neoplasms
Bioregulation of kallikrein-related peptidases 6, 10 and 11 by the kinin B? receptor in breast cancer cells.
Clinical significance of kallikrein-related peptidase (KLK10) mRNA expression in colorectal cancer.
Downregulation of human kallikrein 10 (KLK10/NES1) by CpG island hypermethylation in breast, ovarian and prostate cancers.
Glucocorticoid receptor-mediated expression of kallikrein 10 in human breast cancer cell lines.
Higher expression of human kallikrein 10 in breast cancer tissue predicts tamoxifen resistance.
Human kallikrein 10 ELISA development and validation in breast cancer sera.
Human kallikrein 10, a predictive marker for breast cancer.
Identification of KLK10 as a therapeutic target to reverse trastuzumab resistance in breast cancer.
Intracellular signaling pathways regulate hormone-dependent kallikrein gene expression.
Kallikrein 10 (KLK10) methylation as a novel prognostic biomarker in early breast cancer.
NES1/KLK10 gene represses proliferation, enhances apoptosis and down-regulates glucose metabolism of PC3 prostate cancer cells.
Smad signaling is required to maintain epigenetic silencing during breast cancer progression.
Steroid hormone regulation of the human kallikrein 10 (KLK10) gene in cancer cell lines and functional characterization of the KLK10 gene promoter.
Carcinoma
Clinical significance of kallikrein-related peptidase (KLK10) mRNA expression in colorectal cancer.
Diagnostic and prognostic biomarker potential of kallikrein family genes in different cancer types.
Evaluation of human tissue kallikrein-related peptidases 6 and 10 expression in early gastroesophageal adenocarcinoma.
Expression of the human kallikrein genes 10 (KLK10) and 11 (KLK11) in cancerous and non-cancerous lung tissues.
Overexpression of kallikrein 10 in epithelial ovarian carcinomas.
Prognostic value of human kallikrein 10 expression in epithelial ovarian carcinoma.
Carcinoma, Endometrioid
Overexpression of kallikrein 10 (hK10) in uterine serous papillary carcinomas.
Carcinoma, Hepatocellular
Aberrant DNA methylation profile and frequent methylation of KLK10 and OXGR1 genes in hepatocellular carcinoma.
Diagnostic and prognostic biomarker potential of kallikrein family genes in different cancer types.
Carcinoma, Non-Small-Cell Lung
Frequent transcriptional inactivation of Kallikrein 10 gene by CpG island hypermethylation in non-small cell lung cancer.
Carcinoma, Ovarian Epithelial
Overexpression of kallikrein 10 in epithelial ovarian carcinomas.
Prognostic value of human kallikrein 10 expression in epithelial ovarian carcinoma.
The association with age, human tissue kallikreins 6 and 10 and hemostatic markers for survival outcome from epithelial ovarian cancer.
Carcinoma, Papillary
Overexpression of kallikrein 10 (hK10) in uterine serous papillary carcinomas.
Carcinoma, Renal Cell
Diagnostic and prognostic biomarker potential of kallikrein family genes in different cancer types.
Carcinoma, Squamous Cell
Expression of the human kallikrein genes 10 (KLK10) and 11 (KLK11) in cancerous and non-cancerous lung tissues.
Colonic Neoplasms
The use of kallikrein-related peptidases as adjuvant prognostic markers in colorectal cancer.
Colorectal Neoplasms
Clinical significance of human kallikrein 10 gene expression in colorectal cancer and gastric cancer.
Clinical significance of kallikrein-related peptidase (KLK10) mRNA expression in colorectal cancer.
Evaluation and prognostic significance of human tissue kallikrein-related peptidase 10 (KLK10) in colorectal cancer.
Expression analysis and clinical evaluation of kallikrein-related peptidase 10 (KLK10) in colorectal cancer.
[Expression and single nucleotide polymorphisms of kallikrein 10 in colorectal cancer]
Cysts
The association with age, human tissue kallikreins 6 and 10 and hemostatic markers for survival outcome from epithelial ovarian cancer.
Dermatitis, Atopic
Human tissue kallikrein expression in the stratum corneum and serum of atopic dermatitis patients.
Esophageal Neoplasms
Upregulated KLK10 inhibits esophageal cancer proliferation and enhances cisplatin sensitivity in vitro.
Fibroadenoma
Kallikrein 10 (KLK10) methylation as a novel prognostic biomarker in early breast cancer.
Gastrointestinal Neoplasms
Clinical significance of human kallikrein 10 gene expression in colorectal cancer and gastric cancer.
Infections
Aberrant DNA methylation profile and frequent methylation of KLK10 and OXGR1 genes in hepatocellular carcinoma.
Laryngeal Neoplasms
Identification of molecular targets for immunotherapy of patients with head and neck squamous cell carcinoma.
Lung Neoplasms
Expression of the human kallikrein genes 10 (KLK10) and 11 (KLK11) in cancerous and non-cancerous lung tissues.
Frequent transcriptional inactivation of Kallikrein 10 gene by CpG island hypermethylation in non-small cell lung cancer.
Neoplasm Metastasis
Aberrant upregulation of KLK10 promotes metastasis via enhancement of EMT and FAK/SRC/ERK axis in PDAC.
Development of a survival prediction model for gastric cancer using serine proteases and their inhibitors.
Evaluation and prognostic significance of human tissue kallikrein-related peptidase 10 (KLK10) in colorectal cancer.
Frequent transcriptional inactivation of Kallikrein 10 gene by CpG island hypermethylation in non-small cell lung cancer.
MiR-199b-5p promotes tumor growth and metastasis in cervical cancer by down-regulating KLK10.
Transcriptional Suppression of miR-7 by MTA2 Induces Sp1-Mediated KLK10 Expression and Metastasis of Cervical Cancer.
Neoplasms
A 10-gene classifier for distinguishing head and neck squamous cell carcinoma and lung squamous cell carcinoma.
Aberrant DNA methylation profile and frequent methylation of KLK10 and OXGR1 genes in hepatocellular carcinoma.
Aberrant upregulation of KLK10 promotes metastasis via enhancement of EMT and FAK/SRC/ERK axis in PDAC.
Clinical significance of human kallikrein 10 gene expression in colorectal cancer and gastric cancer.
Clinical significance of kallikrein-related peptidase (KLK10) mRNA expression in colorectal cancer.
Development of a survival prediction model for gastric cancer using serine proteases and their inhibitors.
Diagnostic Value of Serum Kallikrein-Related Peptidases 6 and 10 Versus CA125 in Ovarian Cancer.
Downregulation of human kallikrein 10 (KLK10/NES1) by CpG island hypermethylation in breast, ovarian and prostate cancers.
Elevated tumor tissue protein expression levels of kallikrein-related peptidases KLK10 and KLK11 are associated with a better prognosis in advanced high-grade serous ovarian cancer patients.
Epigenetic events of disease progression in head and neck squamous cell carcinoma.
Evaluation and prognostic significance of human tissue kallikrein-related peptidase 10 (KLK10) in colorectal cancer.
Evaluation of human tissue kallikrein-related peptidases 6 and 10 expression in early gastroesophageal adenocarcinoma.
Expression analysis and clinical evaluation of kallikrein-related peptidase 10 (KLK10) in colorectal cancer.
Frequent transcriptional inactivation of Kallikrein 10 gene by CpG island hypermethylation in non-small cell lung cancer.
Gene expression in poorly differentiated papillary thyroid carcinomas.
Higher expression of human kallikrein 10 in breast cancer tissue predicts tamoxifen resistance.
Human Kallikrein 10 Expression in Surgically Removed Human Pituitary Corticotroph Adenomas: An Immunohistochemical Study.
Human kallikrein 10: a novel tumor marker for ovarian carcinoma?
Human tissue kallikreins and testicular cancer.
Identification of molecular targets for immunotherapy of patients with head and neck squamous cell carcinoma.
Identification of new splice variants and differential expression of the human kallikrein 10 gene, a candidate cancer biomarker.
Identification of single nucleotide polymorphisms in the human kallikrein 10 (KLK10) gene and their association with prostate, breast, testicular, and ovarian cancers.
Kallikrein-related peptidase (KLK10) cessation blunts colorectal cancer cell growth and glucose metabolism by regulating the PI3K/Akt/mTOR pathway.
Kallikrein-related peptidase 10 expression in salivary gland tissues and tumours.
Kallikreins 5, 6 and 10 differentially alter pathophysiology and overall survival in an ovarian cancer xenograft model.
Kallikreins as Markers of Disseminated Tumour Cells in Ovarian Cancer - A Pilot Study.
KLK10 exon 3 unmethylated PCR product concentration: a new potential early diagnostic marker in ovarian cancer? - A pilot study.
Methyl-binding domain protein 2-dependent proliferation and survival of breast cancer cells.
Methylation of multiple genes as a candidate biomarker in non-small cell lung cancer.
MiR-199b-5p promotes tumor growth and metastasis in cervical cancer by down-regulating KLK10.
NES1/KLK10 gene represses proliferation, enhances apoptosis and down-regulates glucose metabolism of PC3 prostate cancer cells.
Overexpression of kallikrein 10 (hK10) in uterine serous papillary carcinomas.
Overexpression of kallikrein 10 in epithelial ovarian carcinomas.
Polymorphisms in Kallikrein7 and 10 genes and oral cancer risks in Taiwan betel quid chewers and smokers.
Prognostic significance of human tissue kallikrein-related peptidases 6 and 10 in gastric cancer.
Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis.
Steroid hormone regulation of the human kallikrein 10 (KLK10) gene in cancer cell lines and functional characterization of the KLK10 gene promoter.
Structural basis for the Zn 2+ inhibition of the zymogen-like kallikrein-related peptidase 10.
The association with age, human tissue kallikreins 6 and 10 and hemostatic markers for survival outcome from epithelial ovarian cancer.
The human kallikrein 10 promoter contains a functional retinoid response element.
Tissue kallikreins: new players in normal and abnormal cell growth?
Transcriptional Suppression of miR-7 by MTA2 Induces Sp1-Mediated KLK10 Expression and Metastasis of Cervical Cancer.
Upregulated KLK10 inhibits esophageal cancer proliferation and enhances cisplatin sensitivity in vitro.
Urinary kallikrein 10 predicts the incurability of gastric cancer.
Use tumor suppressor genes as biomarkers for diagnosis of non-small cell lung cancer.
Neoplasms, Germ Cell and Embryonal
Human tissue kallikreins and testicular cancer.
Ovarian Neoplasms
Diagnostic Value of Serum Kallikrein-Related Peptidases 6 and 10 Versus CA125 in Ovarian Cancer.
Elevated tumor tissue protein expression levels of kallikrein-related peptidases KLK10 and KLK11 are associated with a better prognosis in advanced high-grade serous ovarian cancer patients.
Functional proteomics of kallikrein-related peptidases in ovarian cancer ascites fluid.
icb-1 Gene counteracts growth of ovarian cancer cell lines.
Identification of single nucleotide polymorphisms in the human kallikrein 10 (KLK10) gene and their association with prostate, breast, testicular, and ovarian cancers.
Kallikrein-related peptidase 10 (KLK10) expression and single nucleotide polymorphisms in ovarian cancer survival.
Kallikreins 5, 6 and 10 differentially alter pathophysiology and overall survival in an ovarian cancer xenograft model.
Kallikreins as Markers of Disseminated Tumour Cells in Ovarian Cancer - A Pilot Study.
Parallel overexpression of seven kallikrein genes in ovarian cancer.
Potential markers that complement expression of CA125 in epithelial ovarian cancer.
The serum concentration of human kallikrein 10 represents a novel biomarker for ovarian cancer diagnosis and prognosis.
Three dysregulated miRNAs control kallikrein 10 expression and cell proliferation in ovarian cancer.
Pancreatic Neoplasms
Identification of a Nine-Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival of Pancreatic Cancer.
In-silico analysis of kallikrein gene expression in pancreatic and colon cancers.
Kallikrein-Related Peptidase 6 Is Associated with the Tumour Microenvironment of Pancreatic Ductal Adenocarcinoma.
Peutz-Jeghers Syndrome
Search for the second Peutz-Jeghers syndrome locus: exclusion of the STK13, PRKCG, KLK10, and PSCD2 genes on chromosome 19 and the STK11IP gene on chromosome 2.
Pituitary Neoplasms
Human kallikrein 10 in surgically removed human pituitary adenomas.
Polycystic Kidney Diseases
Identification of new splice variants and differential expression of the human kallikrein 10 gene, a candidate cancer biomarker.
Prostatic Neoplasms
Clinical significance of kallikrein-related peptidase (KLK10) mRNA expression in colorectal cancer.
Downregulation of human kallikrein 10 (KLK10/NES1) by CpG island hypermethylation in breast, ovarian and prostate cancers.
Identification of new splice variants and differential expression of the human kallikrein 10 gene, a candidate cancer biomarker.
NES1/KLK10 gene represses proliferation, enhances apoptosis and down-regulates glucose metabolism of PC3 prostate cancer cells.
The Role of Kallikrein10 (KLK10) Polymorphism in Prostate Cancer Susceptibility.
Psoriasis
Aberrant human tissue kallikrein levels in the stratum corneum and serum of patients with psoriasis: dependence on phenotype, severity and therapy.
Stomach Neoplasms
Clinical significance of human kallikrein 10 gene expression in colorectal cancer and gastric cancer.
Identification of new splice variants and differential expression of the human kallikrein 10 gene, a candidate cancer biomarker.
NES1/KLK10 promotes trastuzumab resistance via activation of PI3K/AKT signaling pathway in gastric cancer.
Overexpression of kallikrein gene 10 is a biomarker for predicting poor prognosis in gastric cancer.
Urinary kallikrein 10 predicts the incurability of gastric cancer.
Testicular Neoplasms
Human tissue kallikreins and testicular cancer.
Uterine Cervical Neoplasms
MiR-199b-5p promotes tumor growth and metastasis in cervical cancer by down-regulating KLK10.
Transcriptional Suppression of miR-7 by MTA2 Induces Sp1-Mediated KLK10 Expression and Metastasis of Cervical Cancer.